Labcorp gets EUA for Pixel at-home COVID-19 kits

By staff writers

December 9, 2020 -- Labcorp has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Pixel by Labcorp, a kit that will enable users to collect COVID-19 test samples at home. The test will be made available over the counter, without a prescription.

Pixel enables users to self-collect their samples in the privacy of their own home; this can help minimize transmission of the virus if the user had to go to a hospital or testing center. Samples can be sent to Labcorp for processing, with results sent to consumers via a web portal. Healthcare providers are available for counseling individuals who test positive for SARS-CoV-2 infection.

Pixel by Labcorp will allow COVID-19 samples to be collected at home. Image courtesy of Labcorp.

Labcorp is making the kit available through its website as well as through retail channels.

In a press release, the FDA noted that Pixel was the first COVID-19 test kit to be marketed directly to consumers without a prescription. It's intended to help consumers determine if they need to quarantine or self-isolate, and to assist with healthcare decisions after discussion with a healthcare provider.

"While many home collection kits can be prescribed with a simple online questionnaire, this newly authorized direct-to-consumer collection kit removes that step from the process, allowing anyone to collect their sample and send it to the lab for processing," said Dr. Jeffrey Shuren, director of the Center for Devices and Radiological Health at the FDA.

Labcorp revenue, earnings surge in Q3
Revenue gains from COVID-19 testing helped propel Labcorp to a 33% increase in revenue in its third quarter. The company said that revenue climbed due...
Labcorp nabs EUA for new COVID-19 molecular test
The U.S. Food and Drug Administration has awarded Labcorp emergency use authorization (EUA) for a new, high-throughput method that uses heat and technology...
Labcorp debuts combined COVID-19, flu, and RSV test
Labcorp has launched a combined test for COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The single-panel test is now available throughout...
Labcorp to offer total COVID-19 antibody testing for free
Labcorp plans to offer total antibody testing at no charge through patients' doctors in support of increased blood plasma donations for use as a possible...
Labcorp reports revenue dip in Q2
The COVID-19 pandemic resulted in a 3.9% drop in revenue for Labcorp in its second quarter.

Copyright © 2020

Last Updated ls 6/22/2021 1:19:18 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current